Daily treatment with IPL344 for up to three years was safe and slowed ALS progression in a small Phase 2a clinical trial, ...

In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands and arms, or breathe without assistance. Since they typically retain the ...

Actor Eric Dane, known for Grey’s Anatomy and Euphoria, has been diagnosed with ALS. Learn more about his journey, his future ...

Eric Dane, best known for his role in “Grey’s Anatomy”, has publicly announced his diagnosis with ALS, a progressive ...

TRE-515, a small molecule inhibitor of deoxycytidine kinase, is being developed for autoimmune diseases and in clinical ...

Four serum neurofilament light chain (NfL) tests showed high accuracy in diagnosing and predicting progression of amyotrophic lateral sclerosis (ALS) in a new study. Investigators said the ...

IPL344 is Immunity Pharma's lead drug candidate. IPL344 was discovered in the Weizmann institute of Science, Israel, at Prof. Irun Cohen's Laboratory. IPL344 is being developed as an intravenous ...

Results from phase 2a trial in ALS patients were published in Muscle and Nerve. Statistically significant 58% to 64% slower ALSFRS-R progression rate in IPL344-treated patients compared to the ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies for neurodegenerative diseases, today announced the submission of an ...